Status:
COMPLETED
Amlodipine Diabetic Hypertension Efficacy Response Trial
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Hypertension
Eligibility:
All Genders
30-75 years
Phase:
PHASE4
Brief Summary
To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of \<130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.
Eligibility Criteria
Inclusion
- Documented evidence of Type 2 diabetes as defined by the ADA guidelines and documented evidence of Hypertension (various SBP/DBP ranges).
Exclusion
- A previous history or intolerance or hypersensitivity to calcium channel blockers, ARBs or ACE inhibitors.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
739 Patients enrolled
Trial Details
Trial ID
NCT00159692
Start Date
March 1 2003
End Date
August 1 2005
Last Update
January 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.